drugset / Trial / NCT02883478

Clinical and Structural Outcome of Conventional Versus Accelerated Corneal Collagen Cross-linking (CXL).

NCT02883478

Phase 1/2 Unknown 40 enrolled Oslo University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Compare different corneal parameters and visual outcome of corneal collagen cross-linking (CXL) with conventional versus accelerated ultraviolet-A irradiation using riboflavin with hydroxypropyl methylcellulose.

Timeline

Start
2012-08
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified Other